Development of Cushing's syndrome in corticotropin-releasing factor transgenic mice

Mary Stenzel-Poore, V. A. Cameron, J. Vaughan, P. E. Sawchenko, W. Vale

Research output: Contribution to journalArticle

213 Citations (Scopus)

Abstract

CRF is released in response to various stressors and regulates ACTH secretion and glucocorticoid production. CRF overproduction has been implicated in affective disorders, such as depression and anorexia nervosa, and may lead to Cushing's syndrome. To test whether CRF overproduction leads to Cushing's syndrome and to develop an animal model of chronic pituitary-adrenal activation, the CRF gene was expressed under control of the metallothionein promoter in transgenic mice. CRF transgenic animals exhibit endocrine abnormalities involving the hypothalamic-pituitary-adrenal axis, such as elevated plasma levels of ACTH and glucocorticoids. These animals display physical changes similar to those of patients with Cushing's syndrome, such as excess fat accumulation, muscle atrophy, thin skin, and alopecia. These findings indicate that chronic production of excess CRF results in sustained stimulation of pituitary corticotrope cells, resulting in elevated ACTH and consequent glucocorticoid overproduction, a condition that leads to the development of Cushing's syndrome. Analysis of CRF mRNA distribution revealed that transgene expression is primarily restricted to cells that express the endogenous CRF gene and does not follow the pattern predicted of a metallothionein-regulated gene. These results suggest that DNA elements located outside of the CRF promoter but present within the CRF intron, coding, or 3′-flanking regions may contribute to the cell type specificity of CRF gene expression.

Original languageEnglish (US)
Pages (from-to)3378-3386
Number of pages9
JournalEndocrinology
Volume130
Issue number6
StatePublished - Jun 1992
Externally publishedYes

Fingerprint

Cushing Syndrome
Corticotropin-Releasing Hormone
Transgenic Mice
Adrenocorticotropic Hormone
Glucocorticoids
Metallothionein
3' Flanking Region
Genetically Modified Animals
Muscular Atrophy
Anorexia Nervosa
Alopecia
Mood Disorders
Transgenes
Introns
Transcriptional Activation
Genes
Animal Models
Fats
Depression
Gene Expression

ASJC Scopus subject areas

  • Endocrinology
  • Endocrinology, Diabetes and Metabolism

Cite this

Stenzel-Poore, M., Cameron, V. A., Vaughan, J., Sawchenko, P. E., & Vale, W. (1992). Development of Cushing's syndrome in corticotropin-releasing factor transgenic mice. Endocrinology, 130(6), 3378-3386.

Development of Cushing's syndrome in corticotropin-releasing factor transgenic mice. / Stenzel-Poore, Mary; Cameron, V. A.; Vaughan, J.; Sawchenko, P. E.; Vale, W.

In: Endocrinology, Vol. 130, No. 6, 06.1992, p. 3378-3386.

Research output: Contribution to journalArticle

Stenzel-Poore, M, Cameron, VA, Vaughan, J, Sawchenko, PE & Vale, W 1992, 'Development of Cushing's syndrome in corticotropin-releasing factor transgenic mice', Endocrinology, vol. 130, no. 6, pp. 3378-3386.
Stenzel-Poore M, Cameron VA, Vaughan J, Sawchenko PE, Vale W. Development of Cushing's syndrome in corticotropin-releasing factor transgenic mice. Endocrinology. 1992 Jun;130(6):3378-3386.
Stenzel-Poore, Mary ; Cameron, V. A. ; Vaughan, J. ; Sawchenko, P. E. ; Vale, W. / Development of Cushing's syndrome in corticotropin-releasing factor transgenic mice. In: Endocrinology. 1992 ; Vol. 130, No. 6. pp. 3378-3386.
@article{b0f4cb3b8c9149c586721efe89746d8c,
title = "Development of Cushing's syndrome in corticotropin-releasing factor transgenic mice",
abstract = "CRF is released in response to various stressors and regulates ACTH secretion and glucocorticoid production. CRF overproduction has been implicated in affective disorders, such as depression and anorexia nervosa, and may lead to Cushing's syndrome. To test whether CRF overproduction leads to Cushing's syndrome and to develop an animal model of chronic pituitary-adrenal activation, the CRF gene was expressed under control of the metallothionein promoter in transgenic mice. CRF transgenic animals exhibit endocrine abnormalities involving the hypothalamic-pituitary-adrenal axis, such as elevated plasma levels of ACTH and glucocorticoids. These animals display physical changes similar to those of patients with Cushing's syndrome, such as excess fat accumulation, muscle atrophy, thin skin, and alopecia. These findings indicate that chronic production of excess CRF results in sustained stimulation of pituitary corticotrope cells, resulting in elevated ACTH and consequent glucocorticoid overproduction, a condition that leads to the development of Cushing's syndrome. Analysis of CRF mRNA distribution revealed that transgene expression is primarily restricted to cells that express the endogenous CRF gene and does not follow the pattern predicted of a metallothionein-regulated gene. These results suggest that DNA elements located outside of the CRF promoter but present within the CRF intron, coding, or 3′-flanking regions may contribute to the cell type specificity of CRF gene expression.",
author = "Mary Stenzel-Poore and Cameron, {V. A.} and J. Vaughan and Sawchenko, {P. E.} and W. Vale",
year = "1992",
month = "6",
language = "English (US)",
volume = "130",
pages = "3378--3386",
journal = "Endocrinology",
issn = "0013-7227",
publisher = "The Endocrine Society",
number = "6",

}

TY - JOUR

T1 - Development of Cushing's syndrome in corticotropin-releasing factor transgenic mice

AU - Stenzel-Poore, Mary

AU - Cameron, V. A.

AU - Vaughan, J.

AU - Sawchenko, P. E.

AU - Vale, W.

PY - 1992/6

Y1 - 1992/6

N2 - CRF is released in response to various stressors and regulates ACTH secretion and glucocorticoid production. CRF overproduction has been implicated in affective disorders, such as depression and anorexia nervosa, and may lead to Cushing's syndrome. To test whether CRF overproduction leads to Cushing's syndrome and to develop an animal model of chronic pituitary-adrenal activation, the CRF gene was expressed under control of the metallothionein promoter in transgenic mice. CRF transgenic animals exhibit endocrine abnormalities involving the hypothalamic-pituitary-adrenal axis, such as elevated plasma levels of ACTH and glucocorticoids. These animals display physical changes similar to those of patients with Cushing's syndrome, such as excess fat accumulation, muscle atrophy, thin skin, and alopecia. These findings indicate that chronic production of excess CRF results in sustained stimulation of pituitary corticotrope cells, resulting in elevated ACTH and consequent glucocorticoid overproduction, a condition that leads to the development of Cushing's syndrome. Analysis of CRF mRNA distribution revealed that transgene expression is primarily restricted to cells that express the endogenous CRF gene and does not follow the pattern predicted of a metallothionein-regulated gene. These results suggest that DNA elements located outside of the CRF promoter but present within the CRF intron, coding, or 3′-flanking regions may contribute to the cell type specificity of CRF gene expression.

AB - CRF is released in response to various stressors and regulates ACTH secretion and glucocorticoid production. CRF overproduction has been implicated in affective disorders, such as depression and anorexia nervosa, and may lead to Cushing's syndrome. To test whether CRF overproduction leads to Cushing's syndrome and to develop an animal model of chronic pituitary-adrenal activation, the CRF gene was expressed under control of the metallothionein promoter in transgenic mice. CRF transgenic animals exhibit endocrine abnormalities involving the hypothalamic-pituitary-adrenal axis, such as elevated plasma levels of ACTH and glucocorticoids. These animals display physical changes similar to those of patients with Cushing's syndrome, such as excess fat accumulation, muscle atrophy, thin skin, and alopecia. These findings indicate that chronic production of excess CRF results in sustained stimulation of pituitary corticotrope cells, resulting in elevated ACTH and consequent glucocorticoid overproduction, a condition that leads to the development of Cushing's syndrome. Analysis of CRF mRNA distribution revealed that transgene expression is primarily restricted to cells that express the endogenous CRF gene and does not follow the pattern predicted of a metallothionein-regulated gene. These results suggest that DNA elements located outside of the CRF promoter but present within the CRF intron, coding, or 3′-flanking regions may contribute to the cell type specificity of CRF gene expression.

UR - http://www.scopus.com/inward/record.url?scp=0026659272&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026659272&partnerID=8YFLogxK

M3 - Article

VL - 130

SP - 3378

EP - 3386

JO - Endocrinology

JF - Endocrinology

SN - 0013-7227

IS - 6

ER -